{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:43:21Z","timestamp":1791924201899,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012797","name":"NorthShore University HealthSystem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.amjmed.2022.03.024","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T02:16:29Z","timestamp":1650593789000},"page":"e279-e287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Sickle Cell Trait and Risk for Common Diseases: Evidence from the UK Biobank"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7245-5763","authenticated-orcid":false,"given":"Joseph","family":"Hulsizer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Kyle","family":"Resurreccion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuqing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skylar","family":"Ladson-Gary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lilly","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Helfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Billings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1343-8752","authenticated-orcid":false,"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2022.03.024_bib0001","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu Rev Pathol"},{"issue":"23","key":"10.1016\/j.amjmed.2022.03.024_bib0002","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2022.03.024_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/JBM.S291394","article-title":"Management of sickle cell disease complications beyond acute chest syndrome","volume":"12","author":"Ogu","year":"2021","journal-title":"J Blood Med"},{"issue":"7","key":"10.1016\/j.amjmed.2022.03.024_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214355","article-title":"Sickle cell disease complications: prevalence and resource utilization","volume":"14","author":"Shah","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.024_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pathol.2016.10.002","article-title":"Sickle cell disease in the older adult","volume":"49","author":"Thein","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.amjmed.2022.03.024_bib0006","unstructured":"Centers for Disease Control and Prevention (CDC). Data & statistics on sickle cell disease. Available at: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html. Accessed August 30, 2021."},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.024_bib0007","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2008.12.020","article-title":"Complications associated with sickle cell trait: a brief narrative review","volume":"122","author":"Tsaras","year":"2009","journal-title":"Am J Med"},{"issue":"9861","key":"10.1016\/j.amjmed.2022.03.024_bib0008","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2022.03.024_bib0009","unstructured":"American Society of Hematology Clinical Practice Guidelines on Sickle Cell Disease. Published 2016. Available at:https:\/\/www.hematology.org\/education\/clinicians\/guidelines-and-quality-care\/clinical-practice-guidelines\/sickle-cell-disease-guidelines. Accessed May 6, 2022."},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.024_bib0010","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3324\/haematol.2018.206060","article-title":"The carrier state for sickle cell disease is not completely harmless","volume":"104","author":"Xu","year":"2019","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.amjmed.2022.03.024_bib0011","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/M18-1161","article-title":"Clinical outcomes associated with sickle cell trait: a systematic review","volume":"169","author":"Naik","year":"2018","journal-title":"Ann Intern Med"},{"issue":"7726","key":"10.1016\/j.amjmed.2022.03.024_bib0012","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"9757","key":"10.1016\/j.amjmed.2022.03.024_bib0013","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.024_bib0014","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1182\/blood-2016-07-727719","article-title":"Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIA","volume":"129","author":"Liem","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.024_bib0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjh.15773","article-title":"Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis","volume":"185","author":"Zhou","year":"2019","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.amjmed.2022.03.024_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159215","article-title":"Association between sickle cell trait and the prevalence and severity of diabetic retinopathy","volume":"11","author":"Al Harbi","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.amjmed.2022.03.024_bib0017","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1464-5491.2004.1134.x","article-title":"Albuminuria in Afro-Caribbeans with Type 2 diabetes mellitus: is the sickle cell trait a risk factor?","volume":"21","author":"Oli","year":"2004","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.amjmed.2022.03.024_bib0018","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/bjo.63.12.837","article-title":"Sickle cell trait and diabetic retinopathy","volume":"63","author":"Page","year":"1979","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.03.024_bib0019","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.08841209","article-title":"Sickle cell trait and development of microvascular complications in diabetes mellitus","volume":"5","author":"Bleyer","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.amjmed.2022.03.024_bib0020","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2016101086","article-title":"Sickle cell trait and the risk of ESRD in blacks","volume":"28","author":"Naik","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.amjmed.2022.03.024_bib0021","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/dc15-0699","article-title":"Sickle cell trait worsens oxidative stress, abnormal blood rheology, and vascular dysfunction in type 2 diabetes","volume":"38","author":"Diaw","year":"2015","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.amjmed.2022.03.024_bib0022","first-page":"309","article-title":"Do Nigerian diabetics with haemoglobin genotype Hb AS have greater risks of developing renal complications and hypertension? A preliminary report","volume":"37","author":"Oli","year":"1985","journal-title":"Trop Geogr Med"},{"issue":"5","key":"10.1016\/j.amjmed.2022.03.024_bib0023","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejim.2004.06.003","article-title":"Sickle cell trait and gender influence type 2 diabetic complications in African patients","volume":"15","author":"Ajayi","year":"2004","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.amjmed.2022.03.024_bib0024","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/dc18-1289","article-title":"Increased prevalence of type 2 diabetes-related complications in combined type 2 diabetes and sickle cell trait","volume":"41","author":"Skinner","year":"2018","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.amjmed.2022.03.024_bib0025","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2014.2157","article-title":"Sickle cell trait\u2013neglected opportunities in the era of genomic medicine","volume":"311","author":"Taylor","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjmed.2022.03.024_bib0026","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semperi.2009.12.006","article-title":"History and current status of newborn screening for hemoglobinopathies","volume":"34","author":"Benson","year":"2010","journal-title":"Semin Perinatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.03.024_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1258\/jms.2008.007063","article-title":"Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005","volume":"15","author":"Streetly","year":"2008","journal-title":"J Med Screen"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322002820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322002820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:28:51Z","timestamp":1757582931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322002820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0002934322002820"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.03.024","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sickle Cell Trait and Risk for Common Diseases: Evidence from the UK Biobank","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}